These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10708125)

  • 1. Determination of acceptable HLA mismatches in highly sensitized patients by soluble HLA class I ELISA inhibition.
    Koelman CA; van Beelen E; Witvliet MD; Doxiadis II; Claas FH
    Transplantation; 2000 Feb; 69(4):656-60. PubMed ID: 10708125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Definition of permissible and immunogenic HLA antigens based on epitope analysis of the HLA specific antibodies produced in sensitized patients.
    Papassavas AC; Stavropoulos-Giokas C; Boletis J; Ioannou S; Iniotaki-Theodoraki A; Kostakis A
    Eur J Immunogenet; 2002 Oct; 29(5):401-7. PubMed ID: 12358849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiscreen serum analysis of highly sensitized renal dialysis patients for antibodies toward public and private class I HLA determinants. Implications for computer-predicted acceptable and unacceptable donor mismatches in kidney transplantation.
    Duquesnoy RJ; White LT; Fierst JW; Vanek M; Banner BF; Iwaki Y; Starzl TE
    Transplantation; 1990 Sep; 50(3):427-37. PubMed ID: 2402792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLAMatchmaker-based strategy to identify acceptable HLA class I mismatches for highly sensitized kidney transplant candidates.
    Duquesnoy RJ; Witvliet M; Doxiadis II; de Fijter H; Claas FH
    Transpl Int; 2004 Jan; 17(1):22-30. PubMed ID: 12955350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of HLAMatchmaker and single-antigen HLA-antibody detection beads for identification of acceptable mismatches in highly sensitized patients awaiting kidney transplantation.
    Goodman RS; Taylor CJ; O'Rourke CM; Lynch A; Bradley JA; Key T
    Transplantation; 2006 May; 81(9):1331-6. PubMed ID: 16699463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific inhibition of HLA class I and II antibodies by soluble antigens--a method for the identification of antibody specificity in sera from alloimmunized individuals.
    Sumitran-Karuppan S; Möller E
    Transplantation; 1994 Sep; 58(6):713-9. PubMed ID: 7940692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-HLA-A, -B, -DR, -DQB1 and -DQA1 antibodies reactive epitope determination with HLAMatchmaker in multipare awaiting list for heart transplant.
    Resse M; Paolillo R; Casamassimi A; Cavalca F; Fiorito C; Maiello C; Napoli C
    Hum Immunol; 2013 Aug; 74(8):937-41. PubMed ID: 23628396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of HLA-specific IGG antibodies using single recombinant HLA alleles: the MonoLISA assay.
    Barnardo MC; Harmer AW; Shaw OJ; Ogg GS; Bunce M; Vaughan RW; Morris PJ; Welsh KI
    Transplantation; 2000 Aug; 70(3):531-6. PubMed ID: 10949199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of acceptable HLA mismatches in immunized patients using single-antigen-expressing cell lines.
    Eijsink C; Zoet YM; Kardol MJ; Witvliet MD; Claas FH; Mulder A; Doxiadis II
    Tissue Antigens; 2007 Apr; 69(4):354-7. PubMed ID: 17389021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epitope analysis of the HLA class I specific antibodies: a useful tool for the detection of the acceptable mismatches for highly sensitized patients.
    Papassavas AC; Stavropoulos-Giokas C; Boletis J; Iniotaki-Theodoraki A; Ioannou S; Stravoskoufi P; Kostakis A
    Transplant Proc; 2002 Sep; 34(6):2053-5. PubMed ID: 12270311
    [No Abstract]   [Full Text] [Related]  

  • 12. Soluble HLA-G circulates in maternal blood during pregnancy.
    Hunt JS; Jadhav L; Chu W; Geraghty DE; Ober C
    Am J Obstet Gynecol; 2000 Sep; 183(3):682-8. PubMed ID: 10992193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLAmatchmaker: a molecularly based algorithm for histocompatibility determination. IV. An alternative strategy to increase the number of compatible donors for highly sensitized patients.
    Duquesnoy RJ; Howe J; Takemoto S
    Transplantation; 2003 Mar; 75(6):889-97. PubMed ID: 12660520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The single antigen expressing lines (SALs) concept: an excellent tool for screening for HLA-specific antibodies.
    Zoet YM; Eijsink C; Kardol MJ; Franke-van Dijk ME; Wilson GL; de Paus R; Mickelson E; Heemskerk M; van den Elsen PJ; Claas FH; Mulder A; Doxiadis II
    Hum Immunol; 2005 May; 66(5):519-25. PubMed ID: 15935889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of HLA class I-specific antibodies by the QuikScreen enzyme-linked immunosorbent assay.
    Lucas DP; Paparounis ML; Myers L; Hart JM; Zachary AA
    Clin Diagn Lab Immunol; 1997 May; 4(3):252-7. PubMed ID: 9144358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acceptable HLA mismatches for highly immunized patients.
    Claas FH; De Meester J; Witvliet MD; Smits JM; Persijn GG; Doxiadis II
    Rev Immunogenet; 1999; 1(3):351-8. PubMed ID: 11256426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification, characterization, and quantitation of soluble HLA antigens in the circulation and peritoneal dialysate of renal patients.
    Gelder FB; McDonald JC; Landreneau MD; McMillan RM; Aultman DF
    Ann Surg; 1991 Jun; 213(6):591-7; discussion 597-9. PubMed ID: 2039290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The predictive value of epitope analysis in highly sensitized patients awaiting renal transplantation.
    Laundy GJ; Bradley BA
    Transplantation; 1995 Apr; 59(8):1207-13. PubMed ID: 7537397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactivity of twenty-two cytotoxic human monoclonal HLA antibodies towards soluble HLA class I in an enzyme-linked immunosorbent assay (PRA-STAT).
    Mulder A; Kardol M; Regan J; Buelow R; Claas F
    Hum Immunol; 1997; 56(1-2):106-13. PubMed ID: 9455499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. II. Verification of the algorithm and determination of the relative immunogenicity of amino acid triplet-defined epitopes.
    Duquesnoy RJ; Marrari M
    Hum Immunol; 2002 May; 63(5):353-63. PubMed ID: 11975979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.